Mark Rosenberg, MD. (Rosenberg), Professor of Medicine, Division of Nephrology and
Hypertension. University of Minnesota
Mark Rosenberg is a nephrologist, Professor of Medicine, and Vice Dean for Education at the University of Minnesota Medical School. In this role he oversees the continuum of medical education. His leadership promotes innovation of teaching methods and continuity of curriculum from pre-med and undergraduate through graduate and continuing medical education.
Rosenberg served as chief of medicine and director of the Primary and Specialty Medicine service line at the Minneapolis VA Health Care System. Prior to this, he was director of the Division of Renal Diseases and Hypertension in the Department of Medicine, where he remains a faculty member. Dr. Rosenberg served on the Council of the American Society of Nephrology and was President in 2019.
Wade Bushman, MD, PhD. (Bushman), Senior Scientist, Department of Urology, University
of Wisconsin.
Dr. Bushman’s laboratory group studies molecular signaling in the mesenchymal-epithelial interactions of prostate development and reactivation of embryonic signaling pathways in prostatic neoplasia. Use mouse models, the Bushman lab is examing the role of Sonic hedgehog and BMP-4 signaling, which regulated prostate ductal budding.
Jose Lopez, MD (Lopez). Professor of Medicine, Division of Hematology University of Washington. Member, Bloodworks NW Research Institute
Dr. Lopez's primary research focus delves into platelet adhesion and von Willebrand factor functions. The laboratory has been involved for many years in studies aimed at understanding the basic mechanisms of platelet adhesion. Initially, these studies were aimed at the synthesis, assembly, posttranslational modifications and defining the ligand-binding sites of the receptor that mediates the first step of platelet adhesion, the glycoprotein (GP) Ib-IX-V complex. These studies are continuing, now focused on the association of the GP Ib-IX-V complex with membrane microdomains known as lipid rafts and downstream signaling after the complex has bound its primary adhesive ligand, von Willebrand factor (VWF), a multimeric polypeptide synthesized in endothelial cells and megakaryocytes.
Delores (Dorrie) J. Lamb, PhD. (Lamb) Professor of Urology, Weill Cornell Medicine
Dr. Lamb is Vice Chair for Research in the Department of Urology and Director of the Center for Reproductive Genomics Dr. Lamb holds the Dow Professorship of Urology and is the Associate Dean for Faculty Affairs.Her research interests are in the fields of urology, male infertility, steroid hormone action, prostate cancer and genitourinary birth defects. Her experience is unique as she has an extensive background in both the clinical diagnostic and the basic science arenas in men's health as well as having a remarkable record of achievement in the mentoring
Robert Flaumenhaft, MD, Phd Professor of Medicine Harvard Medical School, Division of Hemostasis and Thrombosis
Dr. Flaumenhaft received his M.D. and Ph.D. from NYU School of Medicine, completed a fellowship in Hematology/Oncology at Beth Israel Deaconess Medical Center (BIDMC), and received a M.M.Sc. from Harvard Medical School. He is currently a Professor at Harvard Medical School and Chief of the Division of Hemostasis and Thrombosis at BIDMC. His laboratory focuses on platelet and endothelial biology and mechanisms of thrombus formation. He also cares for patients with bleeding or clotting disorders. Dr. Flaumenhaft is Director of the T32 training program entitled, “Program in Blood Coagulation and Vascular Biology”. He also is Director of the BIDMC Organ-on-Chip Facility. He has previously served on or currently serves on several editorial boards in the field of Hemostasis and Thrombosis including Blood, JCI Insight, JTH, Thrombosis and Haemostasis , Thrombosis Research, and Seminars in Thrombosis and Hemostasis. He was Chairman of the Hemostasis and Thrombosis NIH Study Section, scientific co-chair of the ASH annual meeting and Chairman of the FASEB meeting on Functional Disulfide Bonds in Health and Disease. His work in in the field of Hemostasis and Thrombosis has earned him a Junior Faculty Award from the American Society of Hematology, a Career Award from the Burroughs Wellcome Fund, an Established Investigator Award from the American Heart Association, and an Outstanding Investigator Award from NIH. He was elected to the American Society for Clinical Investigation and to the Association of American Physicians. Dr. Flaumenhaft is also the founder of PlateletDiagnostics, a device company that specializes in the development of platelet function tests.